title: [Effect of immunotherapy with allergens in asthmatic children with integral treatment].
abstract: OBJECTIVE
  To analyze the effect of the immunotherapy with allergens (ITA) in asthmatic pediatric patients with integral treatment.
  
  
  METHODS
  We included children with allergic rhinitis and asthma to treatment in the Clinic of Asthma and Allergy. We made a monthly evaluation of symptoms and annual of laboratory tests.
  
  
  RESULTS
  The results are described in averages, G1 followed by G2. They were 16 (12 M/4 F) and 17 (11 M/F) patients with ages of 6.1 +/- 2.8 and 6.2 +/- 2 years. They presented 1.2 +/- 0.5 and 1.3 +/- 0.5 crisis per month and also 4.9 +/- 3.4 and 4.8 +/- 3 hospitalizations per year. In all the treatment began with CGIDS in spray and in 8 and 7 BDP was also used. The use of b-agonists at home was bigger in G1: 3 +/- 2.1 vs 0.6 +/- 0.7 (p = 0.0004). Acute treatment in more occasions was granted in G1: 21 vs 2 (p < 0.0001). It was bigger the number of applications of CGIDS in G1: 30.1 +/- 5.3 vs 15.4 +/- 2.7 (p < 0.0001) and of immunotherapy with allergens 8.1 +/- 9.6 vs 5.1 +/- 6.4 (p = 0.1).
  
  
  CONCLUSIONS
  The asthmatic pediatric patients on integral treatment present a bigger and quicker improvement of their rhinitic and asthmatic symptoms when they are also treated with specific IT, even from the beginning of the treatment, they also improve their general immunity and they present reduction of allergic markers. They also use less medications, they present less acute exacerbation's and less hospitalizations.
authors.affiliation: Clínica de asma y alergia, Hospital General de Zona número 30, Iztacalco.
authors.forename: R
authors.initials: R
authors.lastname: Rodríguez Medina
authors.forename: J L
authors.initials: JL
authors.lastname: López Durán
authors.forename: M R
authors.initials: MR
authors.lastname: Gasca Bauza
authors.forename: E
authors.initials: E
authors.lastname: Cortéz González
authors.forename: E
authors.initials: E
authors.lastname: Zamora Limón
mesh_terms: D000485:Allergens / Q000627:therapeutic use*; D001249:Asthma / Q000628:therapy*; D002648:Child; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male
chemical_list: D000485:Allergens